These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3190366)

  • 21. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.
    I.S.A.M. Study Group
    N Engl J Med; 1986 Jun; 314(23):1465-71. PubMed ID: 2871492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of intracoronary and intravenous methods of thrombolytic streptokinase therapy of patients with myocardial infarct].
    Markov VA; Varvarenko VI; Kun VI; Krylov AL; Stoliarov VA
    Kardiologiia; 1988 May; 28(5):20-3. PubMed ID: 3411854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional significance of predischarge exercise thallium-201 findings following intravenous streptokinase therapy during acute myocardial infarction.
    Touchstone DA; Beller GA; Nygaard TW; Watson DD; Tedesco C; Kaul S
    Am Heart J; 1988 Dec; 116(6 Pt 1):1500-7. PubMed ID: 3195434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction.
    Fine DG; Weiss AT; Sapoznikov D; Welber S; Applebaum D; Lotan C; Hasin Y; Ben-David Y; Koren G; Gotsman MS
    Am J Cardiol; 1986 Sep; 58(6):411-7. PubMed ID: 3751909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of clinical heart insufficiency in patients with acute myocardial infarct treated with intravenous streptokinase].
    Torres Martínez G; Rodríguez García P; Castillo Soria F; Cantón García A; Galcerá Tomás J; Nicolás Franco S; Palazón Sánchez C
    Rev Esp Cardiol; 1990 May; 43(5):300-9. PubMed ID: 2392610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose, brief intravenous streptokinase early in acute myocardial infarction.
    Spann JF; Sherry S; Carabello BA; Mann RH; McCann WD; Gault JH; Gentzler RD; Rosenberg KM; Maurer AH; Denenberg BS; Warner HF; Rubin RN; Malmud LS; Comerota A
    Am Heart J; 1982 Oct; 104(4 Pt 2):939-45. PubMed ID: 6751060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eligibility for streptokinase thrombolysis during evolving acute myocardial infarction. An historical cohort study.
    Costello MW; Rigilano JC
    Fam Pract Res J; 1986; 5(3):177-89. PubMed ID: 3454528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do different doses of intravenous streptokinase alter the frequency of coronary reperfusion in acute myocardial infarction?
    Gottlich CM; Cooper B; Schumacher JR; Hillis LD
    Am J Cardiol; 1988 Nov; 62(13):843-6. PubMed ID: 3177232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of coronary arterial patency and left ventricular function to electrocardiographic changes after streptokinase treatment during acute myocardial infarction.
    Richardson SG; Morton P; Murtagh JG; Scott ME; O'Keeffe DB
    Am J Cardiol; 1988 May; 61(13):961-5. PubMed ID: 3364381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous versus intracoronary streptokinase in acute myocardial infarction.
    Lo YS
    Clin Cardiol; 1985 Dec; 8(12):609-19. PubMed ID: 4075606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction.
    Midgette AS; Wong JB; Beshansky JR; Porath A; Fleming C; Pauker SG
    Med Decis Making; 1994; 14(2):108-17. PubMed ID: 8028463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effect of intravenous administration of streptodecase on the extent of the damage in myocardial infarction].
    Ramazanov DM; Rustamov ChI; Gel'fgat EB
    Klin Med (Mosk); 1990 Jul; 68(7):63-6. PubMed ID: 2232652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous streptokinase in acute myocardial infarction.
    Mayer G; Story WE; Seco JE; Nocero MA; Shaskey DJ; Black MA
    Ann Emerg Med; 1985 May; 14(5):410-5. PubMed ID: 3985460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy.
    Kircher BJ; Topol EJ; O'Neill WW; Pitt B
    Am J Cardiol; 1987 Mar; 59(6):513-5. PubMed ID: 3825886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrinolytic therapy in acute myocardial infarction].
    Beregovich J
    Rev Med Chil; 1987 Feb; 115(2):150-6. PubMed ID: 2957771
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction.
    Lew AS; Laramee P; Cercek B; Rodriguez L; Shah PK; Ganz W
    Circulation; 1985 Nov; 72(5):1053-8. PubMed ID: 4042294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombolytic reperfusion of coronary arteries and the function of the left ventricle in acute myocardial infarction].
    Pomerantsev EV; Savchenko AP; Staroverov II; Zharov IN; Mirrakhimov EM
    Kardiologiia; 1989 Feb; 29(2):13-8. PubMed ID: 2724764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relation between the systemic fibrinolytic status and coronary reperfusion during thrombolytic therapy with streptokinase of patients with acute myocardial infarction].
    Markov VA; Stoliarov VA; Varvarenko VI; Cherniavskaia LI; Karpov RS
    Kardiologiia; 1989 Sep; 29(9):92-4. PubMed ID: 2593482
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergency room infusion of intravenous streptokinase in acute myocardial infarction: feasibility, safety, and hemodynamic consequences.
    Verheugt FW; Küpper AJ; Sterkman LG; Meijer A; Peels CH; Roos JP
    Am Heart J; 1989 May; 117(5):1018-22. PubMed ID: 2711963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.